George Robert E.

Avg. Two Year Performance

53% Avg. Purchase Return
24% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(12%)153%96%98%53%
Purchase Success Rate0 of 11 of 11 of 11 of 11 of 1
Average Sale Return----------
Sale Success Rate----------

Moleculin Biotech, Inc.

Drugs » Biotechnology

Director:

Holdings: 14.66K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--